The iconic rise of Viagra has long been a benchmark of pharmaceutical success, but its legacy within the broader market now raises questions about future yields . Generic versions are undercutting https://networkbookmarks.com/story21498530/the-blue-diamond-and-drug-companies-a-uncertain-opportunity